rdf:type |
|
lifeskim:mentions |
umls-concept:C0034656,
umls-concept:C0138741,
umls-concept:C0205155,
umls-concept:C0239307,
umls-concept:C0281186,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C1522472,
umls-concept:C1551341,
umls-concept:C1552858,
umls-concept:C1552923,
umls-concept:C1552924,
umls-concept:C1705191,
umls-concept:C2603343
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-2-19
|
pubmed:abstractText |
To determine the prostate-specific antigen (PSA) velocity, PSA slope, and PSA doubling time (PSADT) in men with positive biopsies, negative biopsies, and no biopsy indications 4 years after an initial screening; and to use this information to improve the test characteristics in the early detection of prostate cancer and provide normal values for these parameters in screened men with and without evidence of prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1527-9995
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
316-20
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14972481-Adenocarcinoma,
pubmed-meshheading:14972481-Aged,
pubmed-meshheading:14972481-Biopsy, Needle,
pubmed-meshheading:14972481-Disease Progression,
pubmed-meshheading:14972481-Early Diagnosis,
pubmed-meshheading:14972481-Humans,
pubmed-meshheading:14972481-Male,
pubmed-meshheading:14972481-Mass Screening,
pubmed-meshheading:14972481-Middle Aged,
pubmed-meshheading:14972481-Neoplasm Proteins,
pubmed-meshheading:14972481-Netherlands,
pubmed-meshheading:14972481-Organ Size,
pubmed-meshheading:14972481-Predictive Value of Tests,
pubmed-meshheading:14972481-Prostate-Specific Antigen,
pubmed-meshheading:14972481-Prostatic Neoplasms,
pubmed-meshheading:14972481-Randomized Controlled Trials as Topic,
pubmed-meshheading:14972481-Sensitivity and Specificity,
pubmed-meshheading:14972481-Time Factors,
pubmed-meshheading:14972481-Tumor Markers, Biological
|
pubmed:year |
2004
|
pubmed:articleTitle |
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
|
pubmed:affiliation |
Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|